After Southern Miss starter Grayden Harris opened the game with a strikeout, Steven Meier singled and went to second on a walk to Brooks Bryan. After another strikeout, Sean Darnell doubled down the ...

You don't have any notifications. Our premium News+ ad-free experience – only $10 more every 4 weeks!

Middleton (10-1) flashed the form that earned him the moniker of Mississippi’s best collegiate baseball this spring, checking ...

Investors were underwhelmed by the solid earnings posted by Keros Therapeutics, Inc. ( NASDAQ:KROS ) recently. We ...

Scotiabank lowered the firm’s price target on Keros Therapeutics (KROS) to $26 from $41 and keeps an Outperform rating on the shares. The firm is ...

LEXINGTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage ...

Keros Therapeutics, Inc. (KROS) came out with quarterly earnings of $3.62 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $1.21 per share a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Keros Therapeutics’ KROS shares jumped 18.5% yesterday following an announcement that it is exploring strategic options, including a potential sale of the business. To aid the decision process ...

and a $200 million upfront payment from the Takeda Agreement is expected to provide a cash runway into 2029. Price Action: KROS stock is up 16.3% at $12.01 at the last check Thursday.